S.-H. Ignatius Ou, Jason A. Zell, Argyrios Ziogas and Hoda Anton-Culver Prognostic factors for survival of stage I nonsmall cell lung cancer patients Cancer 110
Version of Record online: 14 AUG 2007 | DOI: 10.1002/cncr.22938
The authors identified and analyzed 19,702 patients with stage I nonsmall lung cancer (NSCLC) in the California Cancer Registry and identified independent poor prognostic factors for survival. Poorly differentiated tumors in both stage IA and stage IB NSCLC, stage IB tumors located in nonupper lobe locations, and tumors that measured ≥4 cm all carried an increased risk of mortality. These findings may help guide clinical decision to offer patients adjuvant chemotherapy or help identify high-risk patients to enroll in current and future clinical trials in adjuvant chemotherapy.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field